XML 53 R44.htm IDEA: XBRL DOCUMENT
v3.21.2

License Agreement - Additional Information (Details) - License Agreement - USD ($) | 1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | --- | ---
Feb. 29, 2020 | Feb. 28, 2019 | Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | Dec. 31, 2019
Schedule Of License Agreement [Line Items] |  |  |  |  |  |  |
Payment for upfront fee |  |  |  |  |  |  | $ 225,000
Upfront payment upon execution of agreement |  | $ 25,000 |  |  |  |  |
Upfront payment within first anniversary of license agreement |  | 225,000 |  |  |  |  |
Written notice period for termination of agreement |  |  |  |  | 90 days |  |
Termination period Description |  |  |  |  | WARF may terminate the License Agreement with 90 days written notice if first commercial sale does not occur before December 31, 2031. Unless terminated earlier by the parties, the term of the License Agreement will continue until the last licensed patent expires in all countries. |  |
Investigation New Drug (IND) |  |  |  |  |  |  |
Schedule Of License Agreement [Line Items] |  |  |  |  |  |  |
Expected milestone payment on achieving certain regulatory and commercial milestones |  |  | $ 125,000 |  | $ 125,000 |  |
Milestone payment |  |  | 0 |  | 0 |  |
Royalty payments |  |  |  |  | 0 |  |
Investigation New Drug (IND) | Maximum |  |  |  |  |  |  |
Schedule Of License Agreement [Line Items] |  |  |  |  |  |  |
Expected milestone payment on achieving certain regulatory and commercial milestones |  |  | 17,500,000 |  | 17,500,000 |  |
Investigation New Drug (IND) | Minimum [Member] |  |  |  |  |  |  |
Schedule Of License Agreement [Line Items] |  |  |  |  |  |  |
Expected royalty payments upon first commercial product sale |  |  | 100,000 |  | 100,000 |  |
Initial Closing of Series A Preferred Stock |  |  |  |  |  |  |
Schedule Of License Agreement [Line Items] |  |  |  |  |  |  |
Payment for upfront fee | $ 225,000 |  |  |  |  |  |
Research and Development |  |  |  |  |  |  |
Schedule Of License Agreement [Line Items] |  |  |  |  |  |  |
Payment for upfront fee |  | $ 250,000 |  |  |  |  |
General and Administrative Expenses | Maximum |  |  |  |  |  |  |
Schedule Of License Agreement [Line Items] |  |  |  |  |  |  |
Legal patent fees |  |  | $ 100,000 | $ 100,000 | $ 100,000 | $ 100,000 |

X
- Definition Collaborative arrangements upfront payment. + References No definition available. + Details
Name: | dsgn_CollaborativeArrangementsUpfrontPayment
Namespace Prefix: | dsgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Expected milestone payment on achieving certain regulatory and commercial milestones. + References No definition available. + Details
Name: | dsgn_ExpectedMilestonePaymentOnAchievingCertainRegulatoryAndCommercialMilestones
Namespace Prefix: | dsgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Expected royalty payments upon first commercial product sale. + References No definition available. + Details
Name: | dsgn_ExpectedRoyaltyPaymentsUponFirstCommercialProductSale
Namespace Prefix: | dsgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Legal patent fees. + References No definition available. + Details
Name: | dsgn_LegalPatentFees
Namespace Prefix: | dsgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Notice period description. + References No definition available. + Details
Name: | dsgn_NoticePeriodDescription
Namespace Prefix: | dsgn_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Notice period for termination of agreement. + References No definition available. + Details
Name: | dsgn_NoticePeriodForTerminationOfAgreement
Namespace Prefix: | dsgn_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of license agreement. + References No definition available. + Details
Name: | dsgn_ScheduleOfLicenseAgreementLineItems
Namespace Prefix: | dsgn_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Upfront payment upon execution of agreement. + References No definition available. + Details
Name: | dsgn_UpfrontPaymentUponExecutionOfAgreement
Namespace Prefix: | dsgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Upfront payment within one year. + References No definition available. + Details
Name: | dsgn_UpfrontPaymentWithinOneYear
Namespace Prefix: | dsgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments. + References No definition available. + Details
Name: | us-gaap_ContractualObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.3) -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227 + Details
Name: | us-gaap_RoyaltyExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=dsgn_LicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=dsgn_InvestigationNewDrugMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=dsgn_InitialClosingOfSeriesAPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |